Experimental 'Natural Killer' cell therapy takes on tough blood cancers
Disease control
Ongoing
This early-phase study tests an experimental therapy called NKX019, made from donor immune cells (natural killer cells) engineered to target and kill cancer cells. It is for people with certain blood cancers (like lymphoma or leukemia) that have come back or not responded to othe…
Phase: PHASE1 • Sponsor: Nkarta, Inc. • Aim: Disease control
Last updated May 05, 2026 11:54 UTC